Literature DB >> 10362113

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

N Janin1, N Andrieu, K Ossian, A Laugé, M F Croquette, C Griscelli, M Debré, B Bressac-de-Paillerets, A Aurias, D Stoppa-Lyonnet.   

Abstract

Epidemiological studies in ataxia telangiectasia (AT) families have suggested that AT heterozygotes could have an increased cancer risk, especially breast cancer (BC) in women. It has also been suggested that an increased sensibility of AT heterozygotes to the effect of ionizing radiation could be responsible for the increased BC risk. BC relative risk (RR) estimation in AT heterozygotes within families ascertained through AT children is presented here. Family data collected included demographic characteristics, occurrence of cancers, past radiation exposures and blood samples. DNA samples were studied using seven ATM linked microsatellites markers allowing AT haplotypes reconstitution. The relative risk of BC was assessed using French estimated incidence rates. A significant increase risk of BC is found among obligate ATM heterozygotes with a point estimate of 3.32 (P = 0.002). BC relative risk calculated according to age is significantly increased among the obligate ATM heterozygotes female relatives with an age < or = 44 years (RR = 4.55, P = 0.005). The BC relative risk is statistically borderline among the obligate ATM heterozygote female relatives with an age > or = 45 years (RR = 2.48, P = 0.08). The estimated BC relative risk among ATM heterozygotes is consistent with previously published data. However, the increased risk is only a little higher than classical reproductive risk factors and similar to the risk associated with a first-degree relative affected by BC.

Entities:  

Mesh:

Year:  1999        PMID: 10362113      PMCID: PMC2363038          DOI: 10.1038/sj.bjc.6690460

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.

Authors:  A L Børresen; T I Andersen; S Tretli; A Heiberg; P Møller
Journal:  Genes Chromosomes Cancer       Date:  1990-11       Impact factor: 5.006

2.  Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.

Authors:  E C Pippard; A J Hall; D J Barker; B A Bridges
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

3.  Cohort study analysis with a FORTRAN computer program.

Authors:  M Coleman; A Douglas; C Hermon; J Peto
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

4.  Cancers in 44 families with ataxia-telangiectasia.

Authors:  D Morrell; C L Chase; M Swift
Journal:  Cancer Genet Cytogenet       Date:  1990-11-01

Review 5.  Breast cancer: magnitude of the problem and descriptive epidemiology.

Authors:  J L Kelsey; P L Horn-Ross
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

6.  How accurate is self-reported family history of colorectal cancer?

Authors:  J Aitken; C Bain; M Ward; V Siskind; R MacLennan
Journal:  Am J Epidemiol       Date:  1995-05-01       Impact factor: 4.897

Review 7.  Cancer risks in A-T heterozygotes.

Authors:  D F Easton
Journal:  Int J Radiat Biol       Date:  1994-12       Impact factor: 2.694

8.  Accuracy of family cancer history in breast cancer patients.

Authors:  B Theis; N Boyd; G Lockwood; D Tritchler
Journal:  Eur J Cancer Prev       Date:  1994-07       Impact factor: 2.497

9.  Incidence of cancer in 161 families affected by ataxia-telangiectasia.

Authors:  M Swift; D Morrell; R B Massey; C L Chase
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

10.  Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.

Authors:  M Shayeghi; S Seal; J Regan; N Collins; R Barfoot; N Rahman; A Ashton; M Moohan; R Wooster; R Owen; J M Bliss; M R Stratton; J Yarnold
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more
  24 in total

1.  Global analysis of ATM polymorphism reveals significant functional constraint.

Authors:  Y R Thorstenson; P Shen; V G Tusher; T L Wayne; R W Davis; G Chu; P J Oefner
Journal:  Am J Hum Genet       Date:  2001-07-03       Impact factor: 11.025

Review 2.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

3.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.

Authors:  Shaun P Scott; Regina Bendix; Philip Chen; Raymond Clark; Thilo Dork; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Chen Mao; Vincent C H Chung; Ben-Fu He; Rong-Cheng Luo; Jin-Ling Tang
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

5.  ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Authors:  A Broeks; J H Urbanus; A N Floore; E C Dahler; J G Klijn; E J Rutgers; P Devilee; N S Russell; F E van Leeuwen; L J van 't Veer
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Authors:  Jonine L Bernstein; Robert W Haile; Marilyn Stovall; John D Boice; Roy E Shore; Bryan Langholz; Duncan C Thomas; Leslie Bernstein; Charles F Lynch; Jorgen H Olsen; Kathleen E Malone; Lene Mellemkjaer; Anne-Lise Borresen-Dale; Barry S Rosenstein; Sharon N Teraoka; Anh T Diep; Susan A Smith; Marinela Capanu; Anne S Reiner; Xiaolin Liang; Richard A Gatti; Patrick Concannon
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506

Review 7.  ATM and genome maintenance: defining its role in breast cancer susceptibility.

Authors:  Kum Kum Khanna; Georgia Chenevix-Trench
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

8.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.

Authors:  Patrick Concannon; Robert W Haile; Anne-Lise Børresen-Dale; Barry S Rosenstein; Richard A Gatti; Sharon N Teraoka; T Anh Diep; Laila Jansen; David P Atencio; Bryan Langholz; Marinela Capanu; Xiaolin Liang; Colin B Begg; Duncan C Thomas; Leslie Bernstein; Jørgen H Olsen; Kathleen E Malone; Charles F Lynch; Hoda Anton-Culver; Jonine L Bernstein
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

9.  Gene-panel sequencing and the prediction of breast-cancer risk.

Authors:  Douglas F Easton; Paul D P Pharoah; Antonis C Antoniou; Marc Tischkowitz; Sean V Tavtigian; Katherine L Nathanson; Peter Devilee; Alfons Meindl; Fergus J Couch; Melissa Southey; David E Goldgar; D Gareth R Evans; Georgia Chenevix-Trench; Nazneen Rahman; Mark Robson; Susan M Domchek; William D Foulkes
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

Review 10.  First international workshop of the ATM and cancer risk group (4-5 December 2019).

Authors:  Fabienne Lesueur; Douglas F Easton; Anne-Laure Renault; Sean V Tavtigian; Jonine L Bernstein; Zsofia Kote-Jarai; Rosalind A Eeles; Dijana Plaseska-Karanfia; Lidia Feliubadaló; Banu Arun; Natalie Herold; Beatrix Versmold; Rita Katharina Schmutzler; Tú Nguyen-Dumont; Melissa C Southey; Leila Dorling; Alison M Dunning; Paola Ghiorzo; Bruna Samia Dalmasso; Eve Cavaciuti; Dorothée Le Gal; Nicholas J Roberts; Mev Dominguez-Valentin; Matti Rookus; Alexander M R Taylor; Alisa M Goldstein; David E Goldgar; Dominique Stoppa-Lyonnet; Nadine Andrieu
Journal:  Fam Cancer       Date:  2021-06-14       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.